To determine the in vivo effects of PIK3R3 on tumor formation and invasiveness, HT1080 CD133+ cells with stable PIK3R3 knockdown were grown as flank xenografts in immunodeficient mice. This evidence concerns the gene PIK3R3 and neoplasm.